Next Article in Journal
Energy-Related Assessment of a Hemicellulose-First Concept—Debottlenecking of a Hydrothermal Wheat Straw Biorefinery
Previous Article in Journal
Synthesis and Antimycobacterial Assays of Some New Ethambutol Analogs
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Preparation and Transformations of Acetophenone-Derived Enamino Ketones, BF2-β-Ketoiminates, and BF2-β-Diketonates

Faculty of Chemistry and Chemical Technology, University of Ljubljana, Večna pot 113, 1000 Ljubljana, Slovenia
*
Authors to whom correspondence should be addressed.
Molecules 2025, 30(3), 601; https://doi.org/10.3390/molecules30030601
Submission received: 16 December 2024 / Revised: 24 January 2025 / Accepted: 24 January 2025 / Published: 29 January 2025
(This article belongs to the Section Organic Chemistry)

Abstract

:
A series of differently substituted β-enaminones 2a,b, 4ai, 8ad, and 913, their BF2-β-ketoiminate complexes 5ad, and BF2-β-diketonate complexes 6ad were prepared as model substrates for photochemical transformations. The attempted photochemical transformations of enaminones 2, 4, 8 and BF2-β-ketoiminate complexes 5 failed. On the other hand, irradiation of mixtures of BF2-β-diketonate complexes 6ad and cycloalkanes with UV-A light (365 nm) gave the corresponding De Mayo reaction products 7af in 9–30% yields. The photochemical ring-expansion of acetyl tetralone-derived BF2-complex 6d gave novel diannulated cyclooctane derivatives 7e and 7f, which would be difficult to obtain using conventional cyclization methods.

1. Introduction

Enaminones are versatile reagents and building blocks in organic synthesis. Structurally, they are regarded as the enamino equivalents of 1,3-dicarbonyl compounds, as well as the aza-equivalents of enols. Accordingly, these simple and versatile C3-building blocks can react as 1,3-dielectrophiles at terminal carbon atoms and/or as nucleophiles at the central carbon atom. Since their synthetic potential was recognized a long time ago, enaminones have a long record of applications, not only in organic and heterocyclic chemistry, but also in other chemistry-related fields and their use in various applications continues. Since the first general review on enaminones by Greenhill in 1977 [1], several reviews on different aspects of chemistry of enaminones have been published [2,3,4,5,6,7,8].
In contrast to well-elaborated thermal transformations, photochemical transformations of enaminones have been less studied. The majority of classical photochemical reactions of enaminones are [2+2] cycloadditions, 6π-electrocyclizations, and ene-type transformations, which have been used in the synthesis of saturated nitrogen heterocycles, indoles, natural products, and their analogues [9,10,11]. Recently, the array of photochemical reactions of enaminones was expanded by photocatalytic transformations, such as α-C–H selenylation, thiocyanation, and perfluoroalkylation. These transformations were also used in the synthesis of 1,2-diketones, β-keto esters, and annulation reactions to obtain five- and six-membered heterocycles [10].
BF2-β-diketonates are the cyclic equivalents of 1,3-diketones locked in their enol form. Coordination of β-diketone to Lewis acid (BF3·Et2O) enhances the electrophilic character of the terminal carbon atoms, while retaining a mild nucleophilic character at the central carbon atom. Similarly, BF2-β-ketoiminates are also available from β-enaminones and boron trifluoride etherate. Boron β-diketonates and β-ketoiminates are used as reagents in organic synthesis [12,13,14]. However, they are much better known for interesting optical properties, such as fluorescence, room temperature phosphorescence, and aggregation-induced emission enhancement (AIEE). Therefore, boron β-diketonates and β-ketoiminates are interesting as materials for various optoelectronic applications [15,16,17,18,19,20,21,22,23,24].
In continuation of our long-term interest in the chemistry of enaminones and BF2-β-diketonates and their use in organic synthesis, we recently turned our attention to the application of enaminones as ligands and/or building blocks in transition-metal catalysis [25], in asymmetric organocatalysis [26], and in the synthesis of polyenaminones as recyclable optical- and redox-active materials [27]. By extension, we became interested in using enaminones, BF2-β-ketoiminates, and BF2-β-diketonates as substrates in photochemical and photocatalytic transformations. Therefore, we prepared some model enaminones, BF2-β-ketoiminates, and BF2-β-diketonates and used them as substrates for further photochemical studies. Herein, we report the results of this study, the synthesis and transformations of selected α-unsubstituted enamino ketones and their BF2-complexes, and the photochemical transformations (De Mayo reactions) of BF2- β-diketonates.

2. Results

2.1. Synthesis of Model Enamino Ketones 4

(E)-3-(dimethylamino)-1-phenylprop-2-en-1-one (2a) and its 4′-chloro analogue 2b were prepared in two steps from acetophenone (1a) and 4-chloroacetophenone (1b) by heating with 1.1 equiv. of N,N-dimethylformamide dimethylacetal (DMFDMA) in anh. xylene for 16 h to afford the corresponding N,N-dimethylenaminones 2a and 2b in 85% and 62% yield, respectively. Compounds 2a and 2b were then heated with l.1 equiv. of primary amines 3ae in ethanol in the presence of acetic acid or hydrochloric acid to give the secondary enaminones 4ae in 18–94% yields (Scheme 1, Method A). On the other hand, acid-catalyzed transamination of N,N-dimethylenaminones 2 did not take place with 2-aminopyridine (3f) and N-methylaniline (3g). Transamination products 4f, 4g, and 4h were then obtained by heating 2a and 2b with excess 3f and 3g in toluene or xylene. In the same way, the secondary enaminone 4e was also obtained in 81% yield from enaminone 2b and excess allylamine (3e) (Scheme 1, Method B). Finally, β-anilinochalcone 4i was prepared by acid-catalyzed condensation of dibenzoylmethane (1c) and aniline (3b) (Scheme 1, Method C). Experimental data for compounds 2 and 4 are summarized in Table 1.

2.2. Synthesis and Photochemical Reactions of BF2-β-Ketoiminates 5 and BF2-β-Diketonates 6

Treatment of secondary enaminones 4ac,i with BF3·Et2O in the presence of triethylamine produced the corresponding BF2-β-ketoiminate complexes 5ad in 73–92% yields. Similarly, boron β-diketonates 6ad were prepared from 1,3-diketones 1cf and BF3·Et2O in dichloromethane following the literature procedure [28]. BF2-β-diketonate complexes 6 reacted readily with cyclopentene and cyclohexene under irradiation (365 nm) in dichloromethane to furnish the corresponding cycloalkane insertion products 7af in 9–30% yields. Gratifyingly, novel compounds 7e and 7f are nice examples of a ring-expansion reaction furnishing cyclooctane ring, which is difficult to obtain using conventional cyclization methods (Scheme 2). On the other hand, attempts to carry out De Mayo reaction by irradiation of mixtures of β-ketoiminate complexes 5ad and various alkenes with UV-A light (365 nm) failed. This is in line with, to our knowledge, the only literature report on De Mayo reaction using BF2-β-ketoiminates as substrates [29]. Experimental data for compounds 57 are summarized in Table 2.

2.3. Other Transformations of Model Enamino Ketones 4

As the initially prepared substrates 4 and 5 failed to produce the desired cycloalkane insertion products, additional derivatives of secondary enaminones were prepared and tested for photochemical conversion. Compounds 4b,e,f,i were acylated with di-tert-butyl dicarbonate (Boc2O) in acetonitrile in the presence of 4-(dimethylamino)pyridine (DMAP) to afford the corresponding N-Boc derivatives 8ad in 88–100% yields. On the other hand, reaction of 4c with chlorosulfonyl isocyanate (CSI) in Et2O at 0–20 °C furnished (Z)-{2-benzoyl-3-[(4-cyanophenyl)amino]acryloyl}sulfamoyl chloride (9) as the C-acylation product in 80% yield. Replacement of Et2O with toluene and acetonitrile as solvents gave 9 in 81% and 65% yield, respectively. Somewhat surprisingly, treatment of 4b with excess allyl bromide in the presence of K2CO3 gave a mixture of three products 1012. Subsequent chromatographic separation afforded the C,C-diallylation product 10 in 44% yield, the N-monoallylation product 11 in 40% yield, and the C,N-diallylation product 12 in 7% yield. Attempted methylation of 4e with aq. formaldehyde in formic acid did not give any of the expected methylation products. Instead, 1-allyl-3,5-bis(4-chlorobenzoyl)-1,4-dihydropyridine (13) was isolated in 22% yield (Scheme 3). Experimental data for compounds 813 are summarized in Table 3.
Formations of the products 49 (cf. Scheme 1, Scheme 2 and Scheme 3) were expected and are explainable by general mechanisms for enaminone transamination (compounds 4), boron β-ketoiminate and β-diketonate complex formation (compounds 5 and 6), De Mayo reaction (compounds 7), acylation (compounds 8), and electrophilic substitution (compound 9). On the other hand, formation of a mixture of three allylation products 1012 and dihydropyridine derivative 13 were outside the expected product formation and require some further discussion. The proposed reaction pathway leading to a mixture of 1012 is shown on Scheme 4. Reaction of enaminone 4b with 2 equiv. allyl bromide can take place as initial N-allylation (Path A) and/or C-allylation (Path B) to give the respective monoallylated compounds 11 and/or 14. Further allylation of the N-allyl intermediate 11 can only take place at the carbon atom to give the C,N-diallylated compound 10, while allylation of the C-allyl intermediate 14 can give two products, the C,C-diallylated product 10 and the C,N-diallylated compound 12. Finally, the allyl group in monoallylated compounds 11 and 14 and in diallylated compounds 10 and 12 can migrate from carbon to nitrogen and vice versa via a [3.3] sigmatropic rearrangement (aza-Cope rearrangement) [30,31,32] as proposed in Scheme 4.
A plausible explanation for the formation of 1,4-dihydropyridine derivative 13 is shown in Scheme 5. Under aqueous acidic conditions, the enamine moiety of N-allylenaminone 4e partially hydrolyzes to give the β-keto aldehyde intermediate 15/15′, which reacts with enaminone 4e to afford the bis-enaminone intermediate 16. Subsequent C-hydroxymethylation of 16 with formaldehyde gives the intermediate 17, which undergoes acid-catalyzed cyclative alkylation via elimination of water to furnish the 1,4-dihydropyridine derivative 13.
Unfortunately, the attempted photochemical and photocatalytic transformations of compounds 4 and 8 were unsuccessful. In most cases, no reaction took place, while in some cases, complex inseparable mixtures of products were obtained.

3. Structure Determination and Compound Characterization

The structures of compounds 413 were determined by spectroscopic methods (1H, 13C NMR, IR, HRMS, and UV-vis) and by elemental analyses for C, H, and N. The structures of compounds 5b, 8a, 8c, and 8d (Figures S2–S5) in the solid state were determined by X-Ray diffraction.
In solution, enaminones can exist as mixtures of the E- and the Z-isomers and the predominance of either isomer depends on the structure of enaminone and the solvent [1,2,3,4,5,6,7,8]. NMR spectra of tertiary enaminones 2a,b, 4g,h, and 8ac in CDCl3 exhibited a large vicinal coupling constant, 3JCHCH = 12.3–14.0 Hz, which was in agreement with the E-configuration around the C=C double bond. On the other hand, the NMR spectra of secondary enaminones 4af in CDCl3 exhibited smaller vicinal coupling constant, 3JCHCH = 7.4–8.2 Hz, which was in agreement with the Z-configuration around the C=C double bond. The Z-configuration of 4af in CDCl3 is favored by the intramolecular N–H···O=C hydrogen bond, which is consistent with the observed chemical shift, δ = 10.1–12.2 ppm, for the NH proton. On the basis of the large δ chemical shift around 12.5 ppm, the Z-configuration around the C=C double bond was also assigned to compounds 4i and 9. Furthermore, the chemical shift of the sulfonamide NH proton, δ = 13.9 ppm, supports the intramolecular N–H···O=C hydrogen bond between the sulfonamide and the benzoyl groups attached to the α-carbon atom of 9 (Figure 1).
The absorption spectra of compounds 4, 5, 8, and 9 are shown in Figure S6. Absorption spectra of N-aryl-substituted enaminones 4bd,f,g,i show typical absorption maxima between 350 nm (4g, purple line) and 380 nm (4d, blue line) (Figure S6A). Absorption spectra of oxazaborinines 5 are similar to those of parent enaminones 4; the N-methyloxazaborinine 5a absorbs at 334 nm (brown line), while the N-aryl analogues 5bd absorb between 356 nm (5d, green line) and 373 nm (5c, blue line) (Figure S6B). N-acylation of 4 into product 8 resulted in the blue-shift of absorption maxima, which appear between 300 nm (8c, red line) and 327 nm (8d, blue line) (Figure S6C). Compound 9 with chlorosulfonylaminocarbonyl group at α-position exhibits two distinct absorption maxima at 267 nm and 360 nm (Figure S6D). In summary, the N-aryl-substituted enaminones 4bd,f,g,i and 9 and the respective BF2-complexes 5bd absorb visible light up to 415–470 nm, while the N-Boc-analogues 8a,c,d and N-methyloxazaborinine 5a absorb only UV-A light below 400 nm (Figure S6).

4. Experimental

4.1. General Methods

Melting points were determined on a Kofler micro hot stage and on a Mettler Toledo MP30 automated melting point system (Mettler Toledo, Columbus, OH, USA). The NMR spectra were recorded in CDCl3 and DMSO-d6 using Me4Si as the internal standard on a Bruker Avance III Ultrashield 500 and Bruker Avance Neo 600 instruments (Bruker, Billerica, MA, USA) at 500 and 600 MHz for 1H and at 125 and 150 MHz for 13C nucleus, respectively. Chemical shifts (δ) are given in ppm relative to Me4Si as internal standard (δ = 0 ppm) and vicinal coupling constants (J) are given in hertz (Hz). HRMS spectra were recorded on an Agilent 6224 time-of-flight (TOF) mass spectrometer equipped with a double orthogonal electrospray source under atmospheric pressure ionization (ESI) coupled to an Agilent 1260 high-performance liquid chromatograph (HPLC) (Agilent Technologies, Santa Clara, CA, USA). UV-vis spectra were recorded in MeOH using a Varian Cary Bio50 UV–Visible Spectrophotometer (Agilent Technologies, Santa Clara, CA, USA). Emission spectra were recorded on a PerkinElmer LS 50 B Luminescence spectrophotometer (PerkinElmer, Waltham, MA, USA). Fourier-transform infrared (FT-IR) spectra were obtained on a Bruker FTIR Alpha Platinum spectrophotometer (Bruker, Billerica, MA, USA) using attenuated total reflection (ATR) sampling technique. Microanalyses for C, H, and N were obtained on a Perkin-Elmer CHNS/O Analyzer 2400 Series II (PerkinElmer, Waltham, MA, USA). Column chromatography (CC) was performed on silica gel (Silica gel 60, particle size: 0.035–0.070 mm (Sigma-Aldrich, St. Louis, MO, USA)). Photochemical transformations were performed on a Penn PhD Photoreactor M2 with LED light source (3 W, 365 nm) and air-cooling (Penn Photon Devices, Pennsburg, PA, USA).
Acetophenones 1a and 1b, 1,3-diketones 1cf, N,N-dimethylformamide dimethylacetal (DMFDMA), amines 3ag, acetic acid, 37% hydrochloric acid, di-tert-butyl dicarbonate (Boc2O), chlorosulfonyl isocyanate (CSI), allyl bromide, 37% aqueous formaldehyde, formic acid, cyclopentene, cyclohexene, triethylamine, and BF3·Et2O are commercially available (Sigma-Aldrich, St. Louis, MO, USA).

4.2. General Procedure for the Synthesis of N,N-Dimethylenaminones 2a and 2b

N,N-Dimethylformamide dimethyl acetal (DMFDMA) (1.5 mL, 11.2 mmol) was added to a solution of acetophenone derivative 1 (1.20 g, 10 mmol) in anh. xylene (10 mL) and the mixture was refluxed under argon for 16 h. Volatile components were evaporated in vacuo and the orange–red solid residue was triturated with petroleum ether (20 mL). The precipitate was collected by filtration, washed with petroleum ether (2 × 5 mL), and air-dried to give 2.

4.2.1. (E)-3-(Dimethylamino)-1-phenylprop-2-en-1-one (2a)

Prepared from acetophenone (1a) (1.20 g, 10 mmol) and DMFDMA (1.5 mL, 11.2 mmol). Yield: 1.49 g (85%) of ochre solid, m.p. 93–94 °C, lit. [33] m.p. 90–92 °C. 1H NMR (500 MHz, CDCl3) δ 7.89 (dt, J = 6.9, 1.5 Hz, 2H), 7.80 (d, J = 12.4 Hz, 1H), 7.48–7.36 (m, 3H), 5.71 (d, J = 12.4 Hz, 1H), 3.14 and 2.92 (2 br s, 1:1, 6H). 13C NMR (126 MHz, CDCl3) δ 188.6, 154.2, 140.5, 130.8, 128.1, 127.5, 92.2, 45.0, 37.2. νmax 2905, 2805, 1633, 1581, 1428, 1362, 1273, 1051 cm−1; ESI-HRMS: m/z = 176.1068 [M+H]+, C11H14NO requires m/z = 176.1070. Anal. Calcd. for C11H13NO: C, 75.40; H, 4.93; N, 7,90%. Found: C, 75.59; H, 4.93, N, 7.90%. Physical and spectral data are in agreement with the literature data [33,34,35].

4.2.2. (E)-1-(4-Chlorophenyl)-3-(dimethylamino)prop-2-en-1-one (2b)

Prepared from 4-chloroacetophenone (1b) (1.55 g, 10 mmol) and DMFDMA (1.5 mL, 11.2 mmol). Yield: 1.295 g (62%) of light orange solid, m.p. 87–88 °C, lit. [34] m.p. 85–87 °C. 1H NMR (500 MHz, CDCl3) δ 7.87–7.81 (m, 2H), 7.80 (d, J = 12.3 Hz, 1H), 7.40–7.34 (m, 2H), 5.66 (d, J = 12.3 Hz, 1H), 3.16 and 2.93 (2 br s, 1:1, 6H). Physical and spectral data are in agreement with the literature data [34].

4.3. General Procedures for the Synthesis of Enaminones 4ah

  • General Procedure A (G.P.A).
A mixture of N,N-dimethylenaminone 2 (10 mmol), amine 3 (10 mmol), ethanol (40 mL), and acetic acid (1.5 mL, 25 mmol) or 37% hydrochloric acid (1 mL, 10 mmol), was stirred under reflux for 3–16 h. The reaction mixture was cooled to 0 °C (ice bath), the precipitate was collected by filtration and washed with EtOH–water (1:1, 2 × 5 mL) to give compound 4.
  • General Procedure B (G.P.B).
A two-necked 50 mL flask was charged with N,N-dimethylenaminone 2 (5 mmol), anh. xylene (25 mL), and amine 3 (5 mmol). The flask was then equipped with a reflux condenser and nitrogen inlet adapter. The reaction mixture was stirred under reflux and dry nitrogen was slowly bubbled into the reaction mixture to assist the removal of dimethylamine, evolution of which was monitored by indication with wet litmus paper at the top of reflux condenser. After approximately 12 h, the evolution of dimethylamine ceased (negative wet-litmus test) indicating completion of transamination reaction. Volatile components were evaporated in vacuo and the residue was purified by CC. Fractions containing the product were combined and evaporated in vacuo to give compound 4.

4.3.1. (Z)-3-(methylamino)-1-phenylprop-2-en-1-one (4a)

Prepared from enaminone 2a (1.754 g, 10 mmol) and methylamine hydrochloride (3a) (1.35 g, 20 mmol), G.P.A, reflux for 16 h. Addition of acetic acid or hydrochloric acid was omitted and the product 4a did not precipitate for the reaction mixture. Volatile components were evaporated in vacuo and the residue was purified by CC (EtOAc–hexanes, 1:5). Fractions containing the product were combined and evaporated in vacuo to give compound 4a. Yield: 912 mg (57%) of yellow solid, m.p. 135–137 °C, lit. [36] m.p. 138–139 °C. 1H NMR (500 MHz, CDCl3) δ 10.13 (s, 1H), 7.83–7.74 (m, 2H), 7.45–7.27 (m, 3H), 6.83 (dd, J = 12.9, 7.4 Hz, 1H), 5.61 (d, J = 7.3 Hz, 1H), 2.99 (d, J = 5.1 Hz, 3H). νmax 3071, 2948, 1630 (C=O), 1512, 1422, 1395, 1286, 1058 cm−1. Physical and spectral data are in agreement with the literature data [36,37].

4.3.2. (Z)-1-Phenyl-3-(phenylamino)prop-2-en-1-one (4b)

Prepared from enaminone 2a (1.754 g, 10 mmol) and aniline hydrochloride (3b) (1.30 g, 10 mmol), G.P.A, reflux for 3 h. Yield: 2.111 g (95%) of yellow solid, m.p. 139–140 °C, lit. [38] m.p. 141 °C. 1H NMR (500 MHz, CDCl3) δ 12.15 (d, J = 12.3 Hz, 1H), 7.98–7.92 (m, 2H), 7.57–7.42 (m, 4H), 7.39–7.32 (m, 2H), 7.15–7.06 (m, 3H), 6.04 (d, J = 7.8 Hz, 1H). 13C NMR (126 MHz, CDCl3) δ 191.0, 145.0, 140.2, 139.2, 131.6, 129.8, 128.5, 127.3, 123.7, 116.4, 93.7. νmax 3050, 1659 (C=O), 1542, 1472, 1268, 1239, 1175, 886 cm−1. ESI-HRMS: m/z = 224.1082 [M+H]+, C15H14NO requires m/z = 224.1070. Physical and spectral data are in agreement with the literature data [38,39].

4.3.3. (Z)-4-[(3-Oxo-3-phenylprop-1-en-1-yl)amino]benzonitrile (4c)

Prepared from enaminone 2a (526 mg, 3 mmol), 4-aminobenzonitrile (3c) (390 mg, 3.3 mmol), and acetic acid (1.5 mL), G.P.A, reflux for 16 h. Yield: 622 mg (84%) of yellow solid, m.p. 153–154 °C, lit. [40] m.p. of the (E)-isomer 209–210 °C. 1H NMR (500 MHz, CDCl3) δ 12.18 (d, J = 11.9 Hz, 1H), 7.98–7.91 (m, 2H), 7.66–7.59 (m, 2H), 7.58–7.50 (m, 1H), 7.53–7.43 (m, 3H), 7.17–7.08 (m, 2H), 6.17 (d, J = 8.1 Hz, 1H). 13C NMR (126 MHz, CDCl3) δ 191.9, 144.0, 142.6, 138.5, 134.0, 132.3, 128.6, 127.5, 118.9, 116.0, 106.0, 96.3. νmax 3056, 2223 (C≡N), 1643 (C=O), 1471, 1287, 1243, 1176, 1019 cm−1; ESI-HRMS: m/z = 249.1015 [M+H]+, C16H13N2O requires m/z = 249.1022. Anal. Calcd. for C16H12N2O: C, 77.40; H, 4.87; N, 11.28%. Found: C, 77.04; H, 4.93, N, 10.90%. Physical and spectral data are in agreement with the literature data [40].

4.3.4. (Z)-3-[(4-Methoxyphenyl)amino]-1-phenylprop-2-en-1-one (4d)

Prepared from enaminone 2a (175 mg, 1 mmol), 4-methoxyaniline (3d) (123 mg, 1 mmol), and acetic acid (0.5 mL), G.P.A, reflux for 16 h. The product was purified by CC (Et2O). Fractions containing the product were combined and evaporated in vacuo to give compound 4d. Yield: 45 mg (18%) of yellow solid, m.p. 146–148 °C, lit. [41] 145–147 °C. 1H NMR (500 MHz, CDCl3) δ 12.20 (d, J = 12.4 Hz, 1H), 7.97–7.90 (m, 2H), 7.53–7.40 (m, 4H), 7.09–7.02 (m, 2H), 6.93–6.86 (m, 2H), 5.98 (d, J = 7.7 Hz, 1H), 3.80 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 190.6, 156.4, 145.9, 139.3, 133.8, 131.4, 128.4, 127.2, 117.9, 115.0, 92.9, 55.6. νmax 3060, 2990, 1624 (C=O), 1470, 1290, 1254, 1179, 1030 cm−1. ESI-HRMS: m/z = 254.1176 [M+H]+, C16H16NO2 requires m/z = 254.1176. Physical and spectral data are in agreement with the literature data [41].

4.3.5. (Z)-3-(Allylamino)-1-(4-chlorophenyl)prop-2-en-1-one (4e)

Prepared from enaminone 2b (210 mg, 1 mmol), allylamine (3e) (90 μL, 1.2 mmol), and 37% aq. HCl (3 drops, 1 mmol), reflux for 16 h, G.P.A. The product 4e did not precipitate for the reaction mixture. Volatile components were evaporated in vacuo and the residue was purified by CC (EtOAc–hexanes, 1:1). Fractions containing the product were combined and evaporated in vacuo to give compound 4e. Prepared also from enaminone 2b (2.10 g, 10 mmol) and allylamine (3e) (1.8 mL, 24 mmol) in anh. xylene (25 mL), G.P.B, CC (EtOAc–hexanes, 1:1). Yield: 152 mg (69%, G.P.A) and 1.796 g (81%, G.P.B) of brownish solid, m.p. 60–61 °C. 1H NMR (500 MHz, CDCl3) δ 10.35 (s, 1H), 7.81 (d, J = 8.6 Hz, 2H), 7.38 (d, J = 8.6 Hz, 2H), 6.95 (dd, J = 12.8, 7.5 Hz, 1H), 5.90 (ddt, J = 17.1, 10.4, 5.4 Hz, 1H), 5.69 (d, J = 7.4 Hz, 1H), 5.28 (dq, J = 17.2, 1.6 Hz, 1H), 5.22 (dq, J = 10.2, 1.4 Hz, 1H), 3.89 (tt, J = 5.7, 1.7 Hz, 2H). 13C NMR (126 MHz, CDCl3) δ 188.6, 154.4, 138.1, 137.0, 134.1, 128.5, 128.5, 117.3, 90.4, 51.1. νmax 3278, 2909, 1533, 1274, 1087, 1006, 935, 847, 762 cm−1. ESI-HRMS: m/z = 222.0608 [M+H]+, C12H13ClNO requires m/z = 222.0677.

4.3.6. (Z)-1-Phenyl-3-[(pyridin-2-yl)amino]prop-2-en-1-one (4f)

Prepared from enaminone 2a (876 mg, 5 mmol) and 2-aminopyridine (3f) (470 mg, 5 mmol) in anh. xylene (25 mL), G.P.B, CC (Et2O). Yield: 710 mg (63%) of yellow solid, m.p. 126–128 °C, lit. [42] m.p. 169–170 °C, lit. [43] m.p. 93 °C. 1H NMR (500 MHz, CDCl3) δ 12.16 (d, J = 11.6 Hz, 1H), 8.31 (ddd, J = 4.9, 1.9, 0.8 Hz, 1H), 8.26 (dd, J = 11.6, 8.2 Hz, 1H), 8.00–7.93 (m, 2H), 7.62 (ddd, J = 8.1, 7.3, 1.9 Hz, 1H), 7.56–7.48 (m, 1H), 7.50–7.43 (m, 2H), 6.95 (ddd, J = 7.3, 4.9, 0.9 Hz, 1H), 6.83 (dt, J = 8.2, 0.9 Hz, 1H), 6.15 (d, J = 8.2 Hz, 1H). 13C NMR (126 MHz, CDCl3) δ 191.9, 151.7, 148.5, 142.9, 139.0, 138.4, 131.8, 128.5, 127.5, 118.5, 111.7, 95.2. νmax 3061, 1591, 1536, 1470, 1416, 1230, 1202, 1016 cm−1. ESI-HRMS: m/z = 225.1018 [M+H]+, C14H13N2O requires m/z = 225.1022. Physical and spectral data are in agreement with the literature data [42,43].

4.3.7. (E)-3-[Methyl(phenyl)amino]-1-phenylprop-2-en-1-one (4g)

Prepared from enaminone 2a (876 mg, 5 mmol) and N-methylaniline (3g) (470 mg, 5 mmol) in anh. xylene (25 mL), G.P.B, CC (Et2O). Yield: 840 mg (71%) of beige solid, m.p. 99–101°C, lit. [44] m.p. 110–112 °C. 1H NMR (500 MHz, CDCl3) δ 8.23 (d, J = 12.7 Hz, 1H), 7.98–7.91 (m, 2H), 7.53–7.46 (m, 1H), 7.48–7.41 (m, 2H), 7.42–7.34 (m, 2H), 7.25–7.14 (m, 3H), 6.10 (d, J = 12.7 Hz, 1H), 3.40 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 189.41, 149.95, 146.4, 140.0, 131.4, 129.5, 128.3, 127.7, 124.9, 112.4, 96.9, 37.4. νmax 3052, 3034, 1650 (C=O), 1539, 1491, 1260, 1176, 1020 cm−1. ESI-HRMS: m/z = 238.1222 [M+H]+, C16H16NO requires m/z = 238.1226. Anal. Calcd. for C16H15NO: C, 80.98; H, 6.37; N, 5.90%. Found: C, 80.59; H, 6.51, N, 5.98%. Physical and spectral data are in agreement with the literature data [44].

4.3.8. (E)-1-(4-Chlorophenyl)-3-[methyl(phenyl)amino]prop-2-en-1-one (4h)

Prepared from enaminone 2b (323 mg, 1.5 mmol) and N-methylaniline (3g) (400 μL, 3.7 mmol) in anh. xylene (5 mL), G.P.B, CC (Et2O). Yield: 183 mg (45%) of yellow solid, m.p. 119–120 °C, lit. [45] m.p. 119–120 °C. 1H NMR (500 MHz, CDCl3) δ 8.22 (d, J = 12.6 Hz, 1H), 7.89 (d, J = 8.5 Hz, 2H), 7.43–7.37 (m, 4H), 7.23–7.17 (m, 3H), 6.04 (d, J = 12.6 Hz, 1H), 3.41 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 187.9, 150.4, 146.3, 138.3, 137.5, 129.6, 129.1, 128.5, 125.2, 120.6, 96.3, 37.2. νmax 3065, 2916, 2198, 2163, 2051, 1923, 1675 (C=O), 1639 (C=O), 1572, 1539, 1497, 1466, 1426, 1392, 1347, 1326, 1305, 1267, 1208, 1182, 1158, 1137, 1087, 1056, 1030, 1009, 973, 901, 874, 845, 800, 758, 742, 713, 695, 679, 626, 610 cm−1. ESI-HRMS: m/z = 272.0835 [M+H]+, C16H15ClNO requires m/z = 272.0837. Physical and spectral data are in agreement with the literature data [45].

4.4. (Z)-1,3-Diphenyl-3-(phenylamino)prop-2-en-1-one (4i)

This compound was prepared by a modified literature procedure [46]. Dibenzoylmethane (12b) (11.2 g, 50 mmol) and para-toluenesulfonic acid monohydrate (476 mg, 2.5 mmol) were added to a solution of aniline (3b) (4.56 mL, 5 mmol) in ethanol (100 mL) and the mixture was stirred under reflux for 16 h. Water (50 mL) and charcoal (~1 g) were added, the mixture was stirred under reflux for 5 min, the suspension filtered hot, and the filtrate was left to stand at ~4 °C for 12 h. The precipitate was collected by filtration and re-crystallized from EtOH–H2O (2:1, 250 mL) to give pure compound 4i. Yield: 11.50 g (77%) of yellow crystals, m.p. 102–103 °C, lit. [46] m.p. 102–103 °C, lit. [47] m.p. 144–145 °C, lit. [48] m.p. 101–102 °C. 1H NMR (500 MHz, CDCl3) δ 12.90 (s, 1H), 8.00–7.94 (m, 2H), 7.53–7.30 (m, 8H), 7.17–7.09 (m, 2H), 7.03–6.95 (m, 1H), 6.82–6.77 (m, 2H), 6.09 (s, 1H). 13C NMR (126 MHz, CDCl3) δ 13C NMR (126 MHz, CDCl3) δ 189.8, 161.6, 140.0, 139.6, 136.0, 131.4, 129.8, 128.9, 128.7, 128.5, 127.4, 124.3, 123.4, 97.2. νmax 3019, 1591, 1555, 1510, 1319, 1284, 1215, 1053 cm−1. ESI-HRMS: m/z = 300.1380 [M+H]+, C21H18NO requires m/z = 300.1383. Physical and spectral data are in agreement with the literature data [46,47,48].

4.5. General Procedure for the Synthesis of β-Ketoiminate Complexes 5ad

Compounds 5 a–d were prepared by a modified literature procedure [13,14]. Under argon, Et3N (140 µL, 1 mmol) and BF3·Et2O (370 µL, 3 mmol) were added subsequently to a stirred suspension of enaminone 4 (1 mmol) in anh. dichloromethane (5 mL) and the mixture was stirred under reflux under argon for 4–24 h.
Workup A: Volatile components were evaporated in vacuo and the residue was purified by CC (dry load). Fractions containing the product were combined and evaporated in vacuo to give 5.
Workup B: Volatile components were evaporated in vacuo and the residue was triturated with Et2O (5 mL) and water (5 mL). The precipitate was collected by filtration and washed with Et2O (5 mL) to give 5.

4.5.1. 2,2-Difluoro-3-methyl-6-phenyl-2H-1,3λ4,2λ4-oxazaborinine (5a)

Prepared from enaminone 4a (162 mg, 1 mmol), Et3N (140 µL, 1 mmol), and BF3·Et2O (370 µL, 3 mmol), reflux for 24 h, Workup A, CC (CH2Cl2). Yield: 164 mg (78%) of beige solid, m.p. 128–129 °C. 1H NMR (500 MHz, CDCl3) δ 7.96–7.89 (m, 2H), 7.69 (p, J = 4.5 Hz, 1H), 7.56–7.48 (m, 1H), 7.45 (dd, J = 8.4, 6.9 Hz, 2H), 6.09 (d, J = 5.4 Hz, 1H), 3.40 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 172.1, 161.7, 133.1, 132.6, 128.8, 127.5, 91.9, 39.6. νmax 2921, 1643, 1551, 1491, 1380, 1151, 1013, 893 cm−1. ESI-HRMS: m/z = 209.0936 [M]+, C10H10BF2NO requires m/z = 209.0933. Anal. Calcd. for C10H10BF2NO: C, 57.47; H, 4.82; N, 6.70%. Found: C, 57.78; H, 4.67, N, 6.60%.

4.5.2. 2,2-Difluoro-3,6-diphenyl-2H-1,3λ4,2λ4-oxazaborinine (5b)

Prepared from enaminone 4b (894 mg, 4 mmol), Et3N (560 µL, 4 mmol) and BF3·Et2O (1.48 mL, 12 mmol), reflux for 16 h, Workup B. Yield: 797 mg (73%) of bright yellow solid, m.p. 194–195 °C. 1H NMR (500 MHz, CDCl3) δ 8.06–8.00 (m, 2H), 7.95 (s, 1H), 7.61–7.55 (m, 1H), 7.52–7.43 (m, 6H), 7.41–7.36 (m, 1H), 6.36 (d, J = 5.8 Hz, 1H). 13C NMR (126 MHz, CDCl3) δ 174.3, 159.6, 142.9, 133.3, 132.7, 129.7, 129.0, 128.3, 128.0, 123.5, 93.7. νmax 1609, 1534, 1487, 1364, 1120, 1082, 1015, 998 cm−1. ESI-HRMS: m/z = 271.1090 [M+H]+, C15H13BF2NO requires m/z = 271.1089. Anal. Calcd. for C15H12BF2NO: C, 66.46; H, 4.46; N, 5.17%. Found: C, 66.48; H, 4.39, N, 5.20%. Physical and spectral data are in agreement with the literature data [20].

4.5.3. 4-(2,2-Difluoro-6-phenyl-2H-1,3λ4,2λ4-oxazaborinin-3-yl)benzonitrile (5c)

Prepared from enaminone 4c (248 g, 1 mmol), Et3N (140 µL, 1 mmol) and BF3·Et2O (370 μL, 3 mmol), reflux for 4 h, Workup A, CC (EtOAc–hexanes, 1:5 → EtOAc). Yield: 259 mg (88%) of yellow solid, m.p. 207–209 °C, lit. [19] m.p. 208–210 °C. 1H NMR (500 MHz, CDCl3) δ 8.08–8.02 (m, 2H), 7.98 (s, 1H), 7.79–7.72 (m, 2H), 7.67–7.58 (m, 3H), 7.53 (t, J = 7.8 Hz, 2H), 6.45 (d, J = 6.0 Hz, 1H). 13C NMR (126 MHz, CDCl3) δ 176.5, 159.4, 146.3, 134.2, 133.7, 132.2, 129.2, 128.4, 124.0, 118.2, 111.8, 94.5. νmax 2230, 1595, 1533, 1489, 1352, 1085, 1025, 1009 cm−1. ESI-HRMS: m/z = 296.1045 [M]+, C15H11BF2N2O requires m/z = 296.1042. Anal. Calcd. for C15H11BF2N2O: C, 64.91; H, 3.74; N, 9.46%. Found: C, 64.88; H, 3.75, N, 9.16%. Physical and spectral data are in agreement with the literature data [19].

4.5.4. 2,2-Difluoro-3,4,6-triphenyl-2H-1,3λ4,2λ4-oxazaborinine (5d)

Prepared from enaminone 4i (1.50 g, 5 mmol), Et3N (700 µL, 5 mmol) and BF3·Et2O (1.86 mL, 15 mmol), reflux for 16 h, Workup B. Yield: 1.59 g (92%) of yellow solid, m.p. 195–196 °C, lit. [24] m.p. 195 °C. 1H NMR (500 MHz, CDCl3) δ 8.09–8.02 (m, 2H), 7.60–7.53 (m, 1H), 7.49 (m, 2H), 7.38–7.32 (m, 1H), 7.30–7.13 (m, 9H), 6.41 (s, 1H). 13C NMR (126 MHz, CDCl3) δ 172.35, 170.81, 140.66, 135.08, 133.27, 132.95, 130.62, 128.92, 128.87, 128.74, 128.61, 127.86, 127.49, 127.11, 97.00. νmax 1595, 1566, 1506, 1486, 1231, 1107, 1020, 973 cm−1. ESI-HRMS: m/z = 347.1400 [M]+, C21H16BF2NO requires m/z = 347.1402. Physical and spectral data are in agreement with the literature data [24].

4.6. General Procedure for the Synthesis of Boron Diketonato Complexes 6ad

These compounds were prepared according to a general procedure in the literature [21]. BF3·Et2O (1.86 mL, 15 mmol) was added to a solution of 1,3-diketone 1 (10 mmol) in anh. dichloromethane (10 mL), the mixture was stirred at room temperature for 20 h, and volatile components were evaporated in vacuo. The residue was triturated with Et2O (10 mL), the precipitate was collected by filtration and washed with Et2O (5 mL) to give compound 6.

4.6.1. 2,2-Difluoro-4,6-diphenyl-2H-1,3λ3,2λ4-dioxaborinine (6a)

Prepared from dibenzoylmethane (1c) (2.24 g, 10 mmol) and BF3·Et2O (1.86 mL, 15 mmol) in anh. dichloromethane (10 mL). Yield: 2.31 g (85%) of light yellow solid, m.p. 194–196 °C, lit. [49] m.p. 195–196 °C. 1H NMR (500 MHz, CDCl3) δ 8.19–8.14 (m, 2H), 7.74–7.68 (m, 2H), 7.57 (t, J = 7.9 Hz, 4H), 7.21 (s, 1H). Physical and spectral data are in agreement with the literature data [49].

4.6.2. 2,2-Difluoro-4-methyl-6-phenyl-2H-1,3λ3,2λ4-dioxaborinine (6b)

Prepared from benzoyl acetone (1d) (5.00 g, 30.8 mmol) and BF3·Et2O (6.00 mL, 46.3 mmol) in anh. dichloromethane (30 mL). Yield: 5.09 g (79%) of white solid, m.p. 125–126 °C, lit. [50] m.p. 120–123 °C. 1H NMR (500 MHz, CDCl3) δ 8.08–8.05 (m, 2H), 7.71–7.67 (m, 1H), 7.56–7.51 (m, 2H), 6.58 (s, 1H), 2.42 (s, 3H). νmax 1984, 1898, 1537, 1493, 1356, 1089, 1053, 1018, 777, 706, 679 cm−1. ESI-HRMS: m/z = 227.1040 [M+NH4]+, C10H12BF2NO2 requires m/z = 227.020. Physical and spectral data are in agreement with the literature data [50,51].

4.6.3. 2,2-Difluoro-6-(4-methoxyphenyl)-4-methyl-2H-1,3λ3,2λ4-dioxaborinine (6c)

Prepared from (4-methoxylbenzoyl)acetone (1e) (1.92 g, 10 mmol) and BF3·Et2O (1.86 mL, 15 mmol) in anh. dichloromethane (10 mL). Yield: 1.69 g (70%) of yellowish resin. 1H NMR (500 MHz, CDCl3) δ 8.06 (d, J = 9.0 Hz, 2H), 7.00 (d, J = 9.0 Hz, 2H), 6.46 (s, 1H), 3.92 (s, 3H), 2.37 (s, 3H). Spectral data are in agreement with the literature data [52].

4.6.4. 2,2-Difluoro-4-methyl-5,6-dihydro-2H-2λ4,3λ3-naphtho[1,2-d][1,3,2]dioxaborinine (6d)

Prepared from 2-acetyl-1-tetralone (1f) (5.00 g, 26.5 mmol) and BF3·Et2O (5.00 mL, 39.8 mmol) in anh. dichloromethane (25 mL). Yield: 5.14 g (82%) of yellow solid, m.p. 150–153 °C, lit. [28] m.p. 150–154 °C. 1H NMR (500 MHz, CDCl3) δ 8.14 (dd, J = 7.8, 0.9 Hz, 1H), 7.56 (td, J = 7.5, 1.3 Hz, 1H), 7.40 (t, J = 7.5 Hz, 1H), 7.28 (d, J = 7.3 Hz, 1H), 2.98 (t, J = 7.4 Hz, 2H), 2.71 (t, J = 7.4 Hz, 2H), 2.40 (s, 3H). νmax 2961, 2012, 1523, 1431, 1213, 1167, 1138, 1027, 996, 794, 742, 719 cm−1. ESI-HRMS: m/z = 253.120 [M+NH4]+, C12H14BF2NO2 requires m/z = 253.050. Physical and spectral data are in agreement with the literature data [28].

4.7. General Procedure for the Synthesis of 1,5-Diketones 7af

A 5 mL vial with a screw cap and septum was charged with boron β-diketonate 6 (0.5 mmol), alkene (0.5–5 mmol), acetophenone (1.5 mg, 12 μmol), and dichloromethane or THF (5 mL). The vial was stopped and carefully degassed and purged with nitrogen using the freeze–pump–thaw technique. Then, the vial was mounted into a photoreactor and irradiated with UV-A light (365 nm) at 20 °C for 20 h. The reaction mixture was diluted with dichloromethane (20 mL) and washed with 1 M aq. HCl (15 mL), saturated aq. NaHCO3 (15 mL), and brine (15 mL). The organic phase was dried over anh. sodium sulfate, filtered, and the filtrate was evaporated in vacuo. The residue was purified by CC (ethyl acetate–petroleum ether). Fractions containing the product were combined and evaporated in vacuo to give the product 7.

4.7.1. 2-(2-Benzoylcyclohexyl)-1-phenylethan-1-one (7a)

Prepared from boron β-diketonate 6a (137 mg, 0.5 mmol), cyclohexene (164 mg, 2 mmol), and acetophenone (1.5 mg, 12 μmol) in dichloromethane (5 mL), CC (EtOAc–hexanes, 1:50). Yield: 28 mg (18%) of white resin. 1H NMR (500 MHz, CDCl3) δ 8.01–7.96 (m, 4H), 7.60–7.42 (m, 6H), 3.32 (td, J = 11.2, 3.4 Hz, 1H), 3.13 (dd, J = 13.8, 2.7 Hz, 1H), 2.48 (dd, J = 13.8, 10.0 Hz, 1H), 2.54 (qt, J = 10.2, f3.2 Hz, 1H), 2.01–1.95 (m, 1H), 1.91–1.85 (m, 1H), 1.84–1.79 (m, 1H), 1.78–1.71 (m, 1H), 1.44–1.15 (m, 4H). 13C NMR (126 MHz, CDCl3) δ 203.7, 199.9, 137.3, 137.0, 133.0, 132.9, 128.8, 128.6, 128.3, 128.2, 46.6, 39.0, 33.7, 29.4, 25.9, 23.8, 23.0. νmax 3058, 2927, 2855, 1674, 1596, 1579, 1447, 1279, 1251, 1212, 117, 1002, 981, 944, 751, 690, 663 cm−1. ESI-HRMS: m/z = 307.1695 [MH]+, C21H23O2 requires m/z = 307.1693. Physical and spectral data are in agreement with the literature data [53].

4.7.2. 2-(2-Benzoylcyclopentyl)-1-phenylethan-1-one (7b)

Prepared from boron β-diketonate 6a (68 mg, 0.25 mmol), cyclopentene (130 μL, 1.5 mmol), and acetophenone (0.75 mg, 6 μmol) in dichloromethane (2.5 mL), CC (EtOAc–hexanes, 1:50). Yield: 16 mg (22%) of white resin. 1H NMR (500 MHz, CDCl3) δ 8.00–7.93 (m, 4H), 7.58–7.51 (m, 2H), 7.47 (t, J = 7.7 Hz, 2H), 7.44 (t, J = 7.7 Hz, 2H), 3.52 (dt, J = 9.2, 7.8 Hz,1H), 3.19 (dd, J = 15.0, 5.5 Hz, 1H), 3.00 (pd, J = 8.3, 5.5 Hz, 1H), 2.87 (dd, J = 15.1, 8.5 Hz, 1H), 2.20–2.12 (m, 1H), 2.11–2.02 (m, 1H), 1.83–1.67 (m, 3H), 1.43 (dq, J = 12.5, 8.1 Hz, 1H). 13C NMR (126 MHz, CDCl3) δ 202.4, 199.9, 137.3, 137.0, 133.1, 133.0, 128.7, 128.7, 128.6, 128.4, 52.7, 43.9, 38.9, 32.5, 31.5, 24.8. νmax 3061, 2949, 2869, 1677, 1596, 1579, 1448, 1276, 1220, 1001, 752, 690 cm−1. ESI-HRMS: m/z = 293.1536 [MH]+, C20H21O2 requires m/z = 293.1536. Spectral data are in agreement with the literature data [54].

4.7.3. 1-(2-Benzoylcyclohexyl)propan-2-one (7c)

Prepared from boron β-diketonate 6b (106 mg, 0.5 mmol), cyclohexene (250 mg, 3 mmol), and acetophenone (1.5 mg, 12 μmol) in dichloromethane (5 mL), CC (EtOAc–hexanes, 1:50). Yield: 16 mg (13%) of white resin. 1H NMR (500 MHz, CDCl3) δ 7.91–7.86 (m, 2H), 7.53 (tt, J = 7.3, 1.3 Hz, 1H), 7.44 (t, J = 7.6 Hz, 2H), 3.63 (dt, J = 8.2, 4.0 Hz, 1H), 2.60–2.52 (m, 1H), 2.52 (dd, J = 17.1, 7.2 Hz, 1H), 2.45 (dd, J = 17.1, 5.5 Hz, 1H), 2.00 (s, 3H), 1.87–1.78 (m, 2H), 1.71–1.34 (m, 6H). 13C NMR (126 MHz, CDCl3) δ 208.2, 203.7, 137.0, 133.0, 128.8, 128.3, 46.3, 44.0, 32.8, 30.7, 29.7, 25.7, 23.8, 22.8. νmax 2927, 2857, 1712, 1673, 1447, 1356, 1253, 1214, 1161, 1002, 976, 759, 699 cm−1. ESI-HRMS: m/z = 245.1534 [MH]+, C16H21O2 requires m/z = 245.1536. Physical and spectral data are in agreement with the literature data [53].

4.7.4. 1-[2-(4-Methoxybenzoyl)cyclohexyl]propan-2-one (7d)

Prepared from boron β-diketonate 6c (48 mg, 0.20 mmol), cyclohexene (120 μL, 1.2 mmol), and acetophenone (0.75 mg, 6 μmol) in THF (2.5 mL), CC (EtOAc–hexanes, 1:10). Yield: 5 mg (9%) of brown resin. 1H NMR (500 MHz, CDCl3) δ 7.95 (br d, J = 7.7 Hz, 2H), 6.95 (br d, J = 7.5 Hz, 2H), 3.87 (s, 3H), 3.18 (br t, J = 9.8 Hz, 1H), 2.43–2.31 (m, 2H), 2.20–2.00 (m, 1H), 2.07 (s, 3H), 1.95–1.84 (m, 2H), 1.83–1.72 (m, 2H), 1.43–1.31 (m, 3H), 1.19–1.07 (m, 1H). 13C NMR (126 MHz, CDCl3) δ 208.7, 202.3, 163.7, 130.7, 130.0, 114.0, 55.6, 49.8, 49.2, 35.3, 31.7, 31.5, 30.1, 26.1, 25.8. νmax 2930, 2856, 1708, 1671, 1598, 1510, 1358, 1254, 1169, 1114, 1028, 839, 758 cm−1. ESI-HRMS: m/z = 275.1643 [MH]+, C17H23O3 requires m/z = 275.1642.

4.7.5. 4-Acetyl-1,2,3,3a,4,5,6,11a-octahydro-11H-benzo[a]cyclopenta[d][8]annulen-11-one (7e)

Prepared from boron β-diketonate 6d (59 mg, 0.25 mmol), cyclopentene (130 μL, 1.5 mmol), and acetophenone (1.5 mg, 12 μmol) in dichloromethane (2.5 mL), CC (EtOAc–hexanes, 1:10). Yield: 18 mg (28%) of yellowish resin. 1H NMR (500 MHz, CDCl3) δ 8.02 (dd, J = 7.9, 1.4 Hz, 1H), 7.46 (td, J = 7.4, 1.5 Hz, 1H), 7.35 (td, J = 7.9, 1.1 Hz, 1H), 7.22 (dd, J = 7.5, 0.6 Hz, 1H), 3.97 (td, J = 7.8, 2.4 Hz, 1H), 3.77 (td, J = 14.2, 5.2 Hz, 1H), 2.94 (ddd, J = 14.9, 5.2, 2.9 Hz, 1H), 2.48–2.29 (m, 3H), 2.04 (s, 3H), 2.02–1.86 (m, 2H), 1.82–1.70 (m, 3H), 1.61–1.50 (m, 1H), 1.31–1.18 (m, 1H). 13C NMR (126 MHz, CDCl3) δ 212.1, 204.5, 140.1, 139.4, 133.2, 132.3, 130.1, 127.2, 52.1, 51.3, 46.3, 34.4, 31.7, 31.0, 30.6, 27.8, 23.5. νmax 2941, 2853, 1693, 1663, 1595, 1464, 1443, 1358, 1345, 1306, 1277, 1202, 1179, 759 cm−1. ESI-HRMS: m/z = 257.1540 [MH]+, C17H21O2 requires m/z = 257.1536.

4.7.6. 5-Acetyl-1,3,4,4a,5,6,7,12a-octahydrodibenzo[a,d][8]annulen-12(2H)-one (7f)

Prepared from boron β-diketonate 6d (236 mg, 1.0 mmol), cyclohexene (164 mg, 2 mmol), and acetophenone (1.5 mg, 12 μmol) in dichloromethane (5 mL), CC (EtOAc–hexanes, 1:50). Yield: 80 mg (30%) of yellowish resin. 1H NMR (500 MHz, CDCl3) δ 7.54 (br d, J = 7.4 Hz, 1H), 7.39 (td, J = 7.5, 1.4 Hz, 1H), 7.30 (td, J = 7.6, 0.9 Hz, 1H), 7.13 (br d, J = 7.6 Hz, 1H), 3.21 (dt, J = 15.7, 9.7 Hz, 1H), 3.15 (br s, 1H), 2.94 (dt, J = 15.7, 5.3 Hz, 1H), 2.57–2.42 (m, 2H), 2.11–2.00 (m, 1H), 2.06 (s, 3H), 1.97–1.88 (m, 2H), 1.85–1.71 (m, 2H), 1.60–1.50 (m, 1H), 1.48–1.32 (m, 2H), 1.29–1.21 (m 1H), 1.13–1.02 (m, 1H). 13C NMR (126 MHz, CDCl3) δ 211.6, 207.9, 140.8, 137.9, 131.3, 130.2, 128.4, 126.9, 52.1, 51.8, 38.4, 32.2, 30.5, 30.0, 27.2, 26.2, 24.4, 23.4. νmax 2914, 1848, 1703, 1659, 1230, 954, 925, 764, 682 cm−1. ESI-HRMS: m/z = 271.1690 [MH]+, C18H23O2 requires m/z = 271.1693.

4.8. General Procedure for the Synthesis of Compounds 8ad

A mixture of enaminone 4 (1 mmol) and anh. acetonitrile (5 mL) was stirred at 0 °C (ice bath) for 5 min. Then, Boc2O (327 mg, 1.5 mmol) and DMAP (12 mg, 0.1 mmol) were added, and the mixture was stirred at 0 °C for 10 min. Ice bath was removed, and the mixture was stirred at room temperature for 16 h. Volatile components were evaporated in vacuo and the residue was purified by CC (EtOAc–hexanes). Fractions containing the product were combined and evaporated in vacuo to give compound 8.

4.8.1. tert-Butyl (E)-(3-oxo-3-phenylprop-1-en-1-yl)(phenyl)carbamate (8a)

Prepared from enaminone 4b (224 mg, 1 mmol), CC (EtOAc–hexanes, 1:10). Yield: 297 mg (92%) of yellow solid, m.p. 109–110 °C. 1H NMR (500 MHz, CDCl3) δ 8.60 (d, J = 13.7 Hz, 1H), 7.74–7.69 (m, 2H), 7.53–7.41 (m, 4H), 7.40–7.34 (m, 2H), 7.23–7.19 (m, 2H), 5.79 (d, J = 13.7 Hz, 1H), 1.48 (s, 9H). 13C NMR (126 MHz, CDCl3) δ 190.5, 152.0, 145.4, 138.8, 137.9, 132.2, 129.9, 128.8, 128.5, 128.2, 128.1, 105.2, 83.8, 28.1. νmax 2983, 2969, 1720 (C=O), 1655 (C=O), 1564, 1345, 1270, 1141 cm−1. ESI-HRMS: m/z = 324.1589 [M+H]+, C20H22NO3 requires m/z = 324.1594.

4.8.2. tert-Butyl (E)-allyl(3-(4-chlorophenyl)-3-oxoprop-1-en-1-yl)carbamate (8b)

Prepared from enaminone 4e (444 mg, 2 mmol), CC (EtOAc–hexanes, 1:5). Yield: 644 mg (100%) of yellow solid, m.p. 83–84 °C. 1H NMR (500 MHz, CDCl3) δ 8.40 (d, J = 13.7 Hz, 1H), 7.82 (d, J = 8.6 Hz, 2H), 7.42 (d, J = 8.5 Hz, 2H), 6.20 (d, J = 13.8 Hz, 1H), 5.81 (ddt, J = 17.2, 10.3, 5.1 Hz, 1H), 5.25 (dq, J = 10.5, 1.4 Hz, 1H), 5.19 (dq, J = 17.1, 1.7 Hz, 1H), 4.29 (dt, J = 5.3, 1.8 Hz, 2H), 1.54 (s, 9H). 13C NMR (126 MHz, CDCl3) δ 189.0, 152.1, 144.2, 138.58, 137.4, 131.3, 129.6, 128.9, 117.2, 102.7, 83.9, 47.2, 28.2. νmax 3118, 3010, 2928, 1715 (C=O), 1653 (C=O), 1590, 1577, 1560, 1489, 1456, 1409, 1393, 1368, 1359, 1320, 1283, 1244, 1204, 1172, 1135, 1090, 1045, 1011, 981, 956, 944, 933, 912, 886, 845, 832, 816, 771, 742, 680 635 cm−1. ESI-HRMS: m/z = 322.1203 [M+H]+, C17H21ClNO3 requires m/z = 322.1204.

4.8.3. tert-Butyl (E)-(3-oxo-3-phenylprop-1-en-1-yl)(pyridin-2-yl)carbamate (8c)

Prepared from enaminone 4f (224 mg, 1 mmol), CC (EtOAc–hexanes, 1:5). Yield: 324 mg (100%) of yellow solid, m.p. 105–107 °C. 1H NMR (500 MHz, CDCl3) δ 8.68 (ddd, J = 4.8, 2.0, 0.8 Hz, 1H), 8.50 (d, J = 14.0 Hz, 1H), 7.90 (td, J = 7.7, 2.0 Hz, 1H), 7.76–7.71 (m, 2H), 7.51–7.45 (m, 1H), 7.43–7.36 (m, 3H), 7.28 (dt, J = 7.8, 1.0 Hz, 1H), 5.81 (d, J = 13.9 Hz, 1H), 1.49 (s, 9H). 13C NMR (126 MHz, CDCl3) δ 190.5, 151.5, 151.2, 150.1, 144.1, 139.1, 138.7, 132.2, 128.5, 128.1, 124.0, 123.4, 105.5, 84.2, 28.1. νmax 3012, 2979, 1720 (C=O), 1655 (C=O), 1563, 1467, 1213, 1098 cm−1. ESI-HRMS: m/z = 325.1540 [M+H]+, C19H21N2O3 requires m/z = 325.1547.

4.8.4. tert-Butyl (E/Z)-(3-oxo-1,3-diphenylprop-1-en-1-yl)(phenyl)carbamate (8d)

Prepared from enaminone 4i (299 mg, 1 mmol), CC (EtOAc–hexanes, 1:5). Yield: 352 mg (88%) of light yellow solid, m.p. 113–124 °C, E/Z = 4:1. 1H NMR (500 MHz, CDCl3) δ major isomer 7.88 (d, J = 7.5 Hz, 2H), 7.69–7.60 (m, 2H), 7.60–7.50 (m, 1H), 7.48–7.35 (m, 5H), 7.28–7.21 (m, 1H), 7.19–7.10 (m, 3H), 7.06–6.98 (m, 1H), 6.91 (s, 1H), 1.26 (s, 9H); minor isomer 7.76 (dd, J = 8.3, 1.2 Hz, 2H), 7.47–7.37 (m, 7H), 7.30 (t, J = 7.7 Hz, 2H), 7.27–7.21 (m, 1H), 7.20–7.10 (m, 3H), 6.37 (s, 1H), 1.20 (s, 9H). 13C NMR (126 MHz, CDCl3) δ major isomer 13C NMR (126 MHz, CDCl3) δ 189.8, 153.1, 151.4, 141.7, 138.4, 132.9, 130.1, 129.4, 128.9, 128.6, 128.5, 128.4, 127.4, 127.0, 125.3, 119.0, 81.9, 28.0; minor isomer 192.8, 154.4, 153.5, 143.0, 138.2, 137.1, 132.7, 130.1, 129.5, 128.9, 128.8, 128.3, 128.2, 126.7, 125.5, 121.4, 82.4, 27.8. νmax 2977, 1713 (C=O), 1660 (C=O), 1595, 1491, 1448, 1367, 1339, 1269, 1246, 1153, 1014, 847, 771, 741, 692 cm−1. Anal. Calcd. for C26H25NO3·⅙H2O: C, 77.52; H, 6.69, N, 3.45%. Found: C, 77.59; H, 6.34, N, 3.48%.

4.9. Synthesis of (Z)-{2-Benzoyl-3-[(4-cyanophenyl)amino]acryloyl}sulfamoyl chloride (9)

Under argon, chlorosulfonyl isocyanate (CSI) (130 μL, 1.5 mmol) was added to a suspension of enaminone 4c (248 mg, 1 mmol) in anhydrous Et2O (10 mL) at 0 °C (ice-bath) and the mixture was stirred at 0 °C for 15 minutes. Then, the ice bath was removed and stirring was continued at room temperature (~20 °C) for 1 h. The precipitate was collected by filtration, washed with anh. Et2O (3 × 5 mL) and dried in vacuo over NaOH pellets for 12 h. Yield: 310 mg (80%) of yellowish solid, m.p. 150 °C (decomp.). 1H NMR (600 MHz, CDCl3) δ 13.84 (s, 1H), 12.14 (d, J = 13.4 Hz, 1H), 8.26 (d, J = 13.4 Hz, 1H), 7.69 (br d, J = 8.7 Hz, 2H), 7.67–7.62 (m,1H), 7.59–7.54 (m, 4H), 7.13 (br d, J = 8.7 Hz, 2H). 13C NMR (150 MHz, CDCl3) δ 196.1, 165.7, 156.4, 141.2, 137.6, 134.3, 132.5, 129.0, 128.7, 118.2, 117.8, 110.2, 102.6. νmax 2223 (C≡N), 1775 (C=O), 1717 (C=O), 1672 (C=O), 1629 (C=O), 1588, 1567, 1440, 1414, 1318, 1275, 1177, 907, 841, 814, 762, 734, 709, 661 cm−1.

4.10. Allylation of Enaminone 4b. Synthesis of Compounds 1012

Under argon, allyl bromide (175 μL, 2 mmol) was added to a stirred mixture of enaminone 4b (224 mg, 1 mmol), K2CO3 (500 mg, 3.6 mmol), NaI (12 mg, 0.08 mmol), and anh. acetonitrile (25 mL). The reaction mixture was then stirred under reflux under argon for 16 h. Volatile components were evaporated in vacuo to give a crude mixture of compounds 10, 11, and 12. The residue was purified by CC (EtOAc–hexanes, 1:5). Compound 10 eluted first, followed by elution of compound 12 and compound 11. Fractions containing the products 10, 11, and 12 were combined and evaporated in vacuo to give compounds 10, 11, and 12.

4.10.1. (E)-2-Allyl-1-phenyl-2-[(phenylimino)methyl]pent-4-en-1-one (10)

Yield: 135 mg (44%) of yellow–orange oil. 1H NMR (500 MHz, CDCl3) δ 8.00 (s, 1H), 7.93–7.89 (m, 2H), 7.53–7.49 (m, 1H), 7.44–7.39 (m, 2H), 7.37–7.32 (m, 2H), 7.24–7.19 (m, 1H), 7.04–6.99 (m, 2H), 5.74 (ddt, J = 17.5, 10.2, 7.4 Hz, 2H), 5.12–5.02 (m, 4H), 2.94 (dt, J = 7.4, 1.2 Hz, 4H). 13C NMR (126 MHz, CDCl3) δ 200.0, 166.7, 151.7, 137.2, 132.6, 132.4, 129.2, 129.2, 128.4, 126.0, 120.4, 119.2, 59.9, 38.3. ESI-HRMS: m/z = 304.1687 [M+H]+, C21H22NO requires m/z = 304.1696.

4.10.2. (E)-3-[Allyl(phenyl)amino]-1-phenylprop-2-en-1-one (11)

Yield: 106 mg (40%) of yellow–orange oil. 1H NMR (500 MHz, CDCl3) δ 8.24 (d, J = 12.8 Hz, 1H), 7.90 (dt, J = 7.1, 1.4 Hz, 2H), 7.51–7.46 (m, 1H), 7.46–7.41 (m, 2H), 7.40–7.35 (m, 2H), 7.26–7.23 (m, 2H), 7.19 (td, J = 7.3, 1.1 Hz, 1H), 6.10 (d, J = 12.9 Hz, 1H), 5.94 (ddt, J = 17.2, 10.5, 4.8 Hz, 1H), 5.34–5.26 (m, 2H), 4.39 (dt, J = 4.2, 1.9 Hz, 2H). 13C NMR (126 MHz, CDCl3) δ 189.6, 149.2, 140.1, 131.5, 131.1, 129.7, 129.3, 128.4, 127.8, 125.3, 117.8, 115.6, 97.7, 53.5. ESI-HRMS: m/z = 264.1375 [M+H]+, C18H18NO requires m/z = 264.1383.

4.10.3. (E)-2-{[Allyl(phenyl)amino]methylene}-1-phenylpent-4-en-1-one (12)

Yield: 21 mg (7%) of yellow–orange oil. 1H NMR (500 MHz, CDCl3) δ 7.57–7.54 (m, 2H), 7.42–7.38 (m, 3H), 7.35 (s, 1H), 7.31–7.26 (m, 2H), 7.14–7.09 (m, 1H), 7.06–7.02 (m, 2H), 5.96–5.79 (m, 2H), 5.21 (d, J = 2275.4 Hz, 2H), 4.95 (dd, J = 99.1, 53.9 Hz, 2H), 4.31 (dt, J = 4.6, 1.9 Hz, 2H), 3.12 (dt, J = 5.4, 1.9 Hz, 2H). 13C NMR (126 MHz, CDCl3) δ 197.4, 151.5, 146.0, 141.2, 137.1, 133.5, 129.9, 129.2, 128.6, 128.0, 125.0, 121.9, 117.2, 114.3, 114.3, 55.8, 28.9. ESI-HRMS: m/z = 304.1691 [M+H]+, C21H22NO requires m/z = 304.1696.

4.11. Synthesis of 1-allyl-3,5-bis(4-chlorobenzoyl)-1,4-dihydropyridine (13)

A 5 mL flask was charged with compound 4e (222 mg, 1 mmol) and the flask was cooled to 0 °C (ice bath). Formic acid (700 μL), 37% aq. formaldehyde (1.35 mL), and water (1 mL) were added at 0 °C (ice bath), the flask was equipped with a reflux condenser, and the mixture was stirred at 90 °C for 48 h. The reaction mixture was cooled to room temperature, diluted with 6 M hydrochloric acid (20 mL), and the product was extracted with dichloromethane (3 × 15 mL). The combined organic phase was evaporated in vacuo and the residue was purified by CC (CH2Cl2–MeOH, 50:1). Fractions containing the product were combined and evaporated in vacuo to give 13. Yield: 42 mg (22%) of brownish solid, m.p. 156–159 °C. 1H NMR (500 MHz, CDCl3) δ 7.49 (d, J = 8.4 Hz, 4H), 7.40 (d, J = 8.4 Hz, 4H), 6.65 (s, 2H), 5.79 (ddt, J = 17.0, 10.5, 5.3 Hz, 1H), 5.30 (dd, J = 8.6, 1.8 Hz, 1H), 5.25 (dd, J = 17.2, 1.0 Hz, 1H), 3.82 (dt, J = 5.5, 1.6 Hz, 2H), 3.51 (s, 2H). 13C NMR (150 MHz, CDCl3) δ 193.0, 143.1, 137.4, 137.1, 132.1, 129.9, 128.6, 119.2, 115.7, 56.8, 21.4. νmax 3088, 2827, 2050, 1664, 1610, 1584, 1572, 1483, 1451, 1396, 1374, 1289, 1258, 1201, 1170, 1136, 1087, 1012, 976, 961, 932, 911, 845, 826, 779, 743, 683, 654, 628 cm−1. ESI-HRMS: m/z = 398.0691 [M+H]+, C22H28Cl2NO2 requires m/z = 398.0709.

5. Conclusions

An array of acetophenone-derived enaminones were prepared via the transamination of N,N-dimethylenaminones. The corresponding BF2-β-ketoiminates as well as BF2-β-diketonates were then prepared and tested in De Mayo reactions with cyclic alkenes. While BF2-β-diketonates gave the desired products in low yields, BF2-β-ketoiminates remained unconverted. The photochemical transformation of tricyclic BF2-acetyltetralone-complex resulted in ring expansion to give novel diannulated cyclooctane derivatives, which would be difficult to obtain using conventional cyclization methods. Additionally, N-Boc, α-chlorosulfonylated, C,C-diallylated, N-monoallyated, and C,N-diallylated derivatives of enaminones were prepared. While their attempted photochemical transformations failed, interesting mechanistic insights were made into allylation of enaminones as well as their conversion to 1,4-dihydropyridine derivative.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/molecules30030601/s1, copies of 1H NMR and 13C NMR of compounds 2 and 413; Figure S1: photochemical reaction setup. Figures S2–S5: X-Ray structures of compounds 8a, 8c, 8d, and 5b; Figure S6: absorption spectra of enaminones 4bd,f,g,i, β-ketoiminate complexes 5ad, N-Boc-enaminones 8a,c,d, and compound 9. Table S1. Crystal data and structure refinement for 5b, 8a, 8c, and 8d. References [55,56,57,58,59,60,61] are cited in the supplementary materials.

Author Contributions

Conceptualization, H.B., L.C., U.G., N.P., B.Š. and J.S.; methodology, H.B., L.C., U.G., N.P., B.Š. and J.S.; software, H.B., L.C., U.G., N.P., B.Š. and J.S.; validation, H.B., L.C., U.G., N.P., B.Š. and J.S.; formal analysis, H.B., L.C., N.P., B.Š. and J.S.; investigation, H.B., L.C., U.G., N.P., B.Š. and J.S.; resources, J.S.; data curation, H.B., L.C., N.P. and J.S.; writing—original draft preparation, H.B., L.C., U.G., N.P., B.Š. and J.S.; writing—review and editing, H.B., L.C., U.G., N.P., B.Š., and J.S.; visualization, H.B. and J.S.; supervision, L.C., N.P. and J.S.; project administration, N.P. and J.S.; funding acquisition, U.G., B.Š. and J.S. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by Slovenian Research and Innovation Agency (ARIS), research core funding No. P1-0179.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data presented in this study are available in the main manuscript and in the Supplementary Materials of this manuscript.

Acknowledgments

The NMR and LC-HRMS characterization and elemental analyses of compounds were performed at the Centre for Research Infrastructure at the Faculty of Chemistry and Chemical Technology, University of Ljubljana (IC UL FCCT).

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Greenhill, J.V. Enaminones. Chem. Soc. Rev. 1977, 6, 277–294. [Google Scholar] [CrossRef]
  2. Stanovnik, B.; Svete, J. Synthesis of Heterocycles from Alkyl 3-(Dimethylamino)propenoates and Related Enaminones. Chem. Rev. 2004, 104, 2433–2480. [Google Scholar] [CrossRef] [PubMed]
  3. Šimůnek, P.; Maháček, V. The structure and tautomerism of azo coupled β-Enaminones. Dyes Pigment. 2010, 86, 187–205. [Google Scholar] [CrossRef]
  4. Chattopadhyay, A.K.; Hanessian, S. Cyclic enaminones. Part I: Stereocontrolled synthesis using diastereoselective and catalytic asymmetric methods. Chem. Commun. 2015, 51, 16437–16449. [Google Scholar] [CrossRef]
  5. Chattopadhyay, A.K.; Hanessian, S. Cyclic enaminones. Part II: Applications as versatile intermediates in alkaloid synthesis. Chem. Commun. 2015, 51, 16450–16467. [Google Scholar] [CrossRef]
  6. Huang, J.; Yu, F. Recent Advances in Organic Synthesis Based on N,N-Dimethyl Enaminones. Synthesis 2021, 53, 587–610. [Google Scholar] [CrossRef]
  7. Amaye, I.J.; Haywood, R.D.; Mandzo, E.M.; Wirick, J.J.; Jackson-Ayotunde, P.L. Enaminones as building blocks in drug development: Recent advances in their chemistry, synthesis, and biological properties. Tetrahedron 2021, 83, 131984. [Google Scholar] [CrossRef]
  8. Wang, Z.; Zhao, B.; Liu, Y.; Wan, J.-P. Recent Advances in Reactions Using Enaminone in Water or Aqueous Medium. Adv. Synth. Catal. 2022, 364, 1508–1521. [Google Scholar] [CrossRef]
  9. Siegel, M.G.; Winkler, J.D. Photochemistry of enamines and enaminones. In Enamines; Rappaport, Z., Ed.; Yohn Wiley & Sons: New York, NY, USA, 1994; Chapter 11; pp. 637–679. [Google Scholar] [CrossRef]
  10. Han, Y.; Zhou, L.; Wang, C.; Feng, S.; Ma, R.; Wan, J.-P. Recent advances in visible light-mediated chemical transformations of enaminones. Chin. Chem. Lett. 2024, 35, 108977. [Google Scholar] [CrossRef]
  11. Salaverri, N.; Alemán, J.; Marzo, L. Harnessing the Power of the De Mayo Reaction: Unveiling a Photochemical and Photocatalytic Masked [2+2] Methodology for Organic Synthesis. Adv. Synth. Catal. 2024, 366, 156–167. [Google Scholar] [CrossRef]
  12. Abd-alhamed, H.; Keshe, M.; Alabaas, R. The chemical organic reactions of β-diketones to prepare different β-diketone derivatives, their properties and its applications: A review. Results Chem. 2024, 12, 101860. [Google Scholar] [CrossRef]
  13. Israel, E.M.; Fyfe, J.W.B.; Watson, A.J.B. 11.07—Boron Complexes in Organic Synthesis. In Comprehensive Organometallic Chemistry IV, 4th ed.; Meyer, K., O’hare, D., Eds.; Elsevier: Oxford, UK, 2022; pp. 305–334. [Google Scholar] [CrossRef]
  14. Guieu, S.; Pinto, J.; Silva, V.L.M.; Rocha, J.; Silva, A.M.S. Synthesis, Post-Modification and Fluorescence Properties of Boron Diketonate Complexes. Eur. J. Org. Chem. 2015, 2015, 3423–3426. [Google Scholar] [CrossRef]
  15. Zhang, W.; Ren, Y.-Y.; Zhang, L.-N.; Fan, X.; Fan, H.; Wu, Y.; Zhang, Y.; Kuang, G.-C. Borondifluoride β-diketonate complex as fluorescent organic nanoparticles: Aggregation-induced emission for cellular imaging. RSC Adv. 2016, 6, 101937–101940. [Google Scholar] [CrossRef]
  16. Kamada, K.; Namikawa, T.; Senatore, S.; Matthews, C.; Lenne, P.-F.; Maury, O.; Andraud, C.; Ponce-Vargas, M.; Le Guiennic, B.; Jacquemin, D.; et al. Boron Difluoride Curcuminoid Fluorophores with Enhanced Two-Photon Excited Fluorescence Emission and Versatile Living-Cell Imaging Properties. Chem. Eur. J. 2016, 22, 5219–5232. [Google Scholar] [CrossRef]
  17. Zhou, Y.; Chen, Y.-Z.; Cao, J.-H.; Yang, Q.-Z.; Wu, L.-Z.; Tung, C.-H.; Wu, D.-Y. Dicyanoboron diketonate dyes: Synthesis, photophysical properties and bioimaging. Dye. Pigment. 2015, 112, 162–169. [Google Scholar] [CrossRef]
  18. Tanaka, K.; Chujo, Y. Recent progress of optical functional nanomaterials based on organoboron complexes with β-diketonate, ketoiminate and diiminate. NPG Asia Mater. 2015, 7, e223. [Google Scholar] [CrossRef]
  19. Motverov, M.V.; Lugovik, K.I.; Vataru, G.V.; Minin, A.S.; Pozdina, V.A.; Slepukhin, P.A.; Benassi, E.; Belskaya, N.P. N,O-bidentate BF2-enaminone complexes: Synthesis, electronic structure, photophysical properties, and biological behaviour. Dye. Pigment. 2022, 208, 110848. [Google Scholar] [CrossRef]
  20. Yoshii, R.; Tanaka, K.; Yoshiki, C. Conjugated Polymers Based on Tautomeric Units: Regulation of Main-Chain Conjugation and Expression of Aggregation Induced Emission Property via Boron-Complexation. Macromolecules 2014, 47, 2268–2278. [Google Scholar] [CrossRef]
  21. Yang, D.; Liu, P.; Bai, T.; Kong, J. N,N-Dimethyl-Substituted Boron Ketoiminates for Multicolor Fluorescent Initiators and Polymers. Macromolecules 2020, 53, 3339–3348. [Google Scholar] [CrossRef]
  22. Zhang, X.; Xie, T.; Yang, L.; Sun, X.; Jiang, J.; Zhang, G. General Design Strategy for Aromatic Ketone-Based Single-Component Dual-Emissive Materials. ACS Appl. Mater. Interfaces 2014, 6, 2279–2284. [Google Scholar] [CrossRef]
  23. Macedo, F.P.; Gwengo, C.; Lindeman, S.V.; Smith, M.D.; Gardinier, J.R. β-Diketonate, β-Ketoiminate, and β-Diiminate Complexes of Difluoroboron. Eur. J. Inorg. Chem. 2008, 2008, 3200–3211. [Google Scholar] [CrossRef]
  24. Dohe, J.; Koβmann, J.; Müller, T.J.J. Diversity-oriented four-component synthesis of solid state luminescent difluoro oxazaborinines. Dyes Pigments 2018, 157, 198–217. [Google Scholar] [CrossRef]
  25. Tomažin, U.; Grošelj, U.; Počkaj, M.; Požgan, F.; Štefane, B.; Svete, J. Combinatorial Synthesis of Acacen-Type Ligands and Their Coordination Compounds. ACS Comb. Sci. 2017, 19, 386–396. [Google Scholar] [CrossRef] [PubMed]
  26. Ciber, L.; Požgan, F.; Brodnik, H.; Štefane, B.; Svete, J.; Grošelj, U. Synthesis and Catalytic Activity of Organocatalysts Based on Enaminone and Benzenediamine Hydrogen Bond Donors. Catalysts 2022, 12, 1132. [Google Scholar] [CrossRef]
  27. Kotnik, T.; Menart, S.; Adam, Ž.; Bitenc, J.; Ciber, L.; Grošelj, U.; Petek, N.; Štefane, B.; Svete, J.; Genorio, B. Synthesis and Redox Activity of Polyenaminones for Sustainable Energy Storage Applications. Polymers 2024, 16, 2700. [Google Scholar] [CrossRef]
  28. Štefane, B. Selective Addition of Organolithium Reagents to BF2-Chelates of β-Ketoesters. Org. Lett. 2010, 12, 2900–2903. [Google Scholar] [CrossRef]
  29. Itoh, K.; Okazaki, K.; Sera, A.; Chow, Y.L. The photoaddition of enaminoketonatoboron difluorides with trans-stilbene. Chem. Commun. 1992, 1608–1609. [Google Scholar] [CrossRef]
  30. Wu, P.L.; Chu, M.; Fowler, F.W. The 1-aza-Cope rearrangement. 1. J. Org. Chem. 1988, 53, 963–972. [Google Scholar] [CrossRef]
  31. Wu, P.L.; Fowler, F.W. The 1-aza-Cope rearrangement. 2. J. Org. Chem. 1988, 53, 5988–6005. [Google Scholar] [CrossRef]
  32. Overman, L.E.; Humphreys, P.G.; Welmaker, G.S. The Aza-Cope/Mannich Reaction. Organic Reactions 2011, 75, 747–820. [Google Scholar] [CrossRef]
  33. Benary, E. Über die Einwirkung von Ammoniak und Aminen auf einige aliphatische und aromatische Oxymethylen-ketone. Chem. Ber. 1930, 63, 1573–1577. [Google Scholar] [CrossRef]
  34. Rosa, F.A.; Machado, P.; Bonacorso, H.G.; Zanatta, N.; Martins, M.A.P. Reaction of β-dimethylaminovinyl ketones with hydroxylamine: A simple and useful method for synthesis of 3- and 5-substituted isoxazoles. J. Heterocycl. Chem. 2008, 45, 879–885. [Google Scholar] [CrossRef]
  35. Larina, N.A.; Lokshin, V.; Berthet, J.; Delbaere, S.; Vermeersch, G.; Khodorkovsky, V. Synthesis and photochromism of a series of new 2-unsubstituted 3-(2-benzylbenzoyl)quinolin-4(1H)-ones. Tetrahedron 2010, 66, 8291–8299. [Google Scholar] [CrossRef]
  36. Zhou, S.; Liu, D.-Y.; Wang, S.; Tian, J.-S.; Loh, T.-P. An efficient method for the synthesis of 2-pyridones via C–H bond functionalization. Chem. Commun. 2020, 56, 15020–15023. [Google Scholar] [CrossRef] [PubMed]
  37. Geng, H.; Zhang, X.; Chang, M.; Zhou, L.; Wu, W.; Zhang, X. Ruthenium-Catalyzed Asymmetric Hydrogenation of β-Keto- enamines: An Efficient Approach to Chiral γ-Amino Alcohols. Adv. Synth. Catal. 2011, 353, 3039–3043. [Google Scholar] [CrossRef]
  38. Hoffmann, S.; Hanh, N.T.; Mandl, K.; Brezesinski, G.; Günther, E. Vinamid-Mesogene–[4-n-Alkoxy-phenyl]-[β-(4-n-alkoxy-phenyl)amino-vinyl]-ketone. Z. Chem. 1986, 26, 103–104. [Google Scholar] [CrossRef]
  39. Haak, E. Ruthenium Complexes of Electronically Coupled Cyclopentadienone Ligands—Catalysts for Transformations of Propargyl Alcohols. Eur. J. Org. Chem. 2007, 2007, 2815–2824. [Google Scholar] [CrossRef]
  40. Suresh, S.; Das, S.; Waidha, K.; Maity, R.; Basu, B. Multi-Component Approach for Synthesis of Quinolinyl-1,4-dihydropyridines, Evaluation of Cytotoxicity against MCF7 and Molecular Docking Studies. ChemistrySelect 2020, 5, 10501–10510. [Google Scholar] [CrossRef]
  41. Yang, J.; Wang, C.; Xie, X.; Li, H.; Li, Y. Acid-Catalyzed Cascade Reactions of Enaminones with Aldehydes: C–H Functionalization To Afford 1,4-Dihydropyridines. Eur. J. Org. Chem. 2010, 2010, 4189–4193. [Google Scholar] [CrossRef]
  42. Wu, W.; Wang, Z.; Shen, Q.; Liu, Q.; Chen, H. Fe-Catalyzed enaminone synthesis from ketones and amines. Org. Biomol. Chem. 2019, 17, 6753–6756. [Google Scholar] [CrossRef]
  43. Wan, J.-P.; Hu, D.; Liu, Y.; Li, L.; Wen, C. Copper-catalyzed intramolecular oxidative amination of enaminone C–H bond for the synthesis of imidazo [1,2-a]pyridines. Tetrahedron Lett. 2016, 57, 2880–2883. [Google Scholar] [CrossRef]
  44. Wang, F.; Sun, W.; Wang, Y.; Jiang, Y.; Loh, T.-P. Highly Site-Selective Metal-Free C–H Acyloxylation of Stable Enamines. Org. Lett. 2018, 20, 1256–1260. [Google Scholar] [CrossRef] [PubMed]
  45. Chu, J.-Y.H.; Murty, B.S.R.; Fedor, L. Nucleophilic substitution reactions of trans-3-methoxy-4’-substituted acrylophenones. J. Am. Chem. Soc. 1976, 98, 3632–3635. [Google Scholar] [CrossRef]
  46. Roberts, E.; Turner, E.E. CCXXXIX.—The factors controlling the formation of some derivatives of quinoline, and a new aspect of the problem of substitution in the quinoline series. J. Chem. Soc. 1927, 1832–1857. [Google Scholar] [CrossRef]
  47. Xie, C.; Feng, L.; Li, W.; Ma, X.; Liu, Y.; Ma, C. Efficient synthesis of pyrrolo [1,2-a]quinoxalines catalyzed by a Brønsted acid through cleavage of C–C bonds. Org. Biomol. Chem. 2016, 14, 8529–8535. [Google Scholar] [CrossRef]
  48. Palimkar, S.S.; More, V.S.; Srinivasan, K.V. Simple and Efficient One-Pot, Three-Component, Solvent-Free Synthesis of β-Enaminones via Sonogashira Coupling–Michael Addition Sequences. Synth. Commun. 2008, 38, 1456–1469. [Google Scholar] [CrossRef]
  49. Ono, K.; Yoshikawa, K.; Tsuji, Y.; Yamaguchi, H.; Uozumi, R.; Tomura, M.; Taga, K.; Saito, K. Synthesis and photoluminescence properties of BF2 complexes with 1,3-diketone ligands. Tetrahedron 2007, 63, 9354–9358. [Google Scholar] [CrossRef]
  50. Kumari, A.; Fernandes, R.A. BX3-Mediated Intermolecular Formation of Functionalized 3-Halo-1H-indenes via Cascade Halo-Nazarov-Type Cyclization. Synthesis 2020, 52, 2245–2258. [Google Scholar] [CrossRef]
  51. Kersten, L.; Roesner, S.; Hilt, G. Synthesis and Characterization of Polycarbonyl Compounds via their BF2-Adducts. Org. Lett. 2010, 12, 4920–4923. [Google Scholar] [CrossRef]
  52. Saho, S.R.; Sarkar, D.; Somu, P.; Paul, S.; Lönnecke, P. Unprecedented Rearrangement of β-Difluoroboryloxy Ethers: A Route to C-2 Alkyl-chromenones. Synlett 2022, 33, 1723–1728. [Google Scholar] [CrossRef]
  53. Wang, L.-C.; Jang, H.-Y.; Roh, Y.; Lynch, V.; Schultz, A.J.; Wang, X.; Krische, M.J. Diastereoselective Cycloreductions and Cycloadditions Catalyzed by Co(dpm)2-Silane (dpm = 2,2,6,6-tetramethylheptane-3,5-dionate): Mechanism and Partitioning of Hydrometallative versus Anion Radical Pathways. J. Am. Chem. Soc. 2002, 124, 9448–9453. [Google Scholar] [CrossRef] [PubMed]
  54. Baik, T.-G.; Luis, A.L.; Wang, L.-C.; Krische, M.J. Diastereoselective Cobalt-Catalyzed Aldol and Michael Cycloreductions. J. Am. Chem. Soc. 2001, 123, 5112–5113. [Google Scholar] [CrossRef] [PubMed]
  55. CrysAlis PRO; Agilent Technologies UK Ltd.: Oxfordshire, UK, 2011.
  56. Dolomanov, O.V.; Bourhis, L.J.; Gildea, R.J.; Howard, J.A.K.; Puschmann, H. OLEX2: A complete structure solution, refinement and analysis program. J. Appl. Cristallogr. 2009, 42, 339–341. [Google Scholar] [CrossRef]
  57. Sheldrick, G.M. A short history of SHELX. Acta Crystallogr. A 2008, 64, 112–122. [Google Scholar] [CrossRef]
  58. Sheldrick, G.M. SHELXT—Integrated space-group and crystal-structure determination. Acta Crystallogr. Sect. Found. Adv. 2015, 71, 3–8. [Google Scholar] [CrossRef]
  59. Sheldrick, G.M. Crystal structure refinement with SHELXL. Acta Crystallogr. Sect. C Struct. Chem. 2015, 71, 3–8. [Google Scholar] [CrossRef]
  60. Macrae, C.F.; Edgington, P.R.; McCabe, P.; Pidcock, E.; Shields, G.P.; Taylor, R.; Towler, M.; van de Streek, J. Mercury: Visualization and analysis of crystal structures. J. Appl. Crystallogr. 2006, 39, 453–457. [Google Scholar] [CrossRef]
  61. Spek, A.L. Single-crystal structure validation with the program PLATON. J. Appl. Crystallogr. 2003, 36, 7–13. [Google Scholar] [CrossRef]
Scheme 1. Synthesis of 1-aryl-3-(substituted amino)propen-1-ones 4ah and (Z)-1,3-diphenyl-3-(phenylamino)prop-2-en-1-one (4i).
Scheme 1. Synthesis of 1-aryl-3-(substituted amino)propen-1-ones 4ah and (Z)-1,3-diphenyl-3-(phenylamino)prop-2-en-1-one (4i).
Molecules 30 00601 sch001
Scheme 2. Synthesis of boron β-ketoiminate complexes 5ad, boron β-diketonate complexes 6ad and De Mayo reaction products 7af.
Scheme 2. Synthesis of boron β-ketoiminate complexes 5ad, boron β-diketonate complexes 6ad and De Mayo reaction products 7af.
Molecules 30 00601 sch002
Scheme 3. Other transformations of enaminones 4b,c,e,f,i. Synthesis of N-Boc-enaminones 8ad, (Z)-{2-benzoyl-3-[(4-cyanophenyl)amino]acryloyl}sulfamoyl chloride (9), allylation products 1012, and 1,4-dihydropyridine derivative 13.
Scheme 3. Other transformations of enaminones 4b,c,e,f,i. Synthesis of N-Boc-enaminones 8ad, (Z)-{2-benzoyl-3-[(4-cyanophenyl)amino]acryloyl}sulfamoyl chloride (9), allylation products 1012, and 1,4-dihydropyridine derivative 13.
Molecules 30 00601 sch003
Scheme 4. The proposed reaction pathway for the formation of compounds 1012.
Scheme 4. The proposed reaction pathway for the formation of compounds 1012.
Molecules 30 00601 sch004
Scheme 5. Plausible explanation for the formation of compound 13.
Scheme 5. Plausible explanation for the formation of compound 13.
Molecules 30 00601 sch005
Figure 1. The structures of enaminones 2, 4, 8, and 9 in CDCl3 solution determined by NMR.
Figure 1. The structures of enaminones 2, 4, 8, and 9 in CDCl3 solution determined by NMR.
Molecules 30 00601 g001
Table 1. Selected experimental data for amines 3ag and enaminones 2a,b and 4ai.
Table 1. Selected experimental data for amines 3ag and enaminones 2a,b and 4ai.
TransformationArR1R2MethodE or ZYield (%)
1a2aPhMeMe-E85
1b2b4-ClC6H4MeMe-E62
2a+3a4aPhMeHAZ57
2a+3b4bPhPhHAZ95
2a+3c4cPh4-NCC6H4HAZ84
2a+3d4dPh4-MeOC6H4HAZ18
2b+3e4e4-ClC6H4allylHAZ69
2b+3e4e4-ClC6H4allylHBZ81
2a+3f4fPh2-pyridylHBZ63
2a+3g4gPhPhMeBE71
2b+3g4h4-ClC6H4PhMeBE45
1c+3b4i---CZ77
Table 2. Selected experimental data for compounds 5ad, 6ad, and 7af.
Table 2. Selected experimental data for compounds 5ad, 6ad, and 7af.
TransformationArR1R2nYield (%)
4a    5a-HMe-78
4b    5b-HPh-73
4c    5c-H4-NCC6H4-88
4i    5d-PhPh-92
1c    6aPhPh--85
1d    6bPhMe--79
1d    6c4-MeOC6H4Me--70
1f    6d----82
6a    7aPhPh-218
6a    7bPhPh-122
6b    7cPhMe-213
6c    7d4-MeOC6H4Me-29
6d    7e---128
6d    7f---230
Table 3. Selected experimental data for compounds 8ad and 913.
Table 3. Selected experimental data for compounds 8ad and 913.
TransformationArR1R2SolventYield (%)
4b    8aPhPhHMeCN92
4e    8b4-ClC6H4allylHMeCN100
4f    8cPh2-pyridylHMeCN100
4i    8dPhPhPhMeCN88
4c    94-NCC6H4--MeCN65
4c    94-NCC6H4--Et2O80
4c    94-NCC6H4--toluene81
4b    10---MeCN44
4b    11---MeCN40
4b    12---MeCN7
4e    134-ClC6H4--H2O-HCO2H22
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Brodnik, H.; Ciber, L.; Grošelj, U.; Petek, N.; Štefane, B.; Svete, J. Preparation and Transformations of Acetophenone-Derived Enamino Ketones, BF2-β-Ketoiminates, and BF2-β-Diketonates. Molecules 2025, 30, 601. https://doi.org/10.3390/molecules30030601

AMA Style

Brodnik H, Ciber L, Grošelj U, Petek N, Štefane B, Svete J. Preparation and Transformations of Acetophenone-Derived Enamino Ketones, BF2-β-Ketoiminates, and BF2-β-Diketonates. Molecules. 2025; 30(3):601. https://doi.org/10.3390/molecules30030601

Chicago/Turabian Style

Brodnik, Helena, Luka Ciber, Uroš Grošelj, Nejc Petek, Bogdan Štefane, and Jurij Svete. 2025. "Preparation and Transformations of Acetophenone-Derived Enamino Ketones, BF2-β-Ketoiminates, and BF2-β-Diketonates" Molecules 30, no. 3: 601. https://doi.org/10.3390/molecules30030601

APA Style

Brodnik, H., Ciber, L., Grošelj, U., Petek, N., Štefane, B., & Svete, J. (2025). Preparation and Transformations of Acetophenone-Derived Enamino Ketones, BF2-β-Ketoiminates, and BF2-β-Diketonates. Molecules, 30(3), 601. https://doi.org/10.3390/molecules30030601

Article Metrics

Back to TopTop